Strong Industry Position Samsung Biologics is a leading CDMO with the largest capacity and fastest throughput in the industry, making it an attractive partner for biopharmaceutical companies seeking reliable manufacturing solutions at every development stage.

Sustainable Leadership The company’s recent recognition with a Platinum rating from EcoVadis signals a strong commitment to sustainability, which can appeal to clients prioritizing environmentally responsible partners.

Global Expansion With new facilities in Korea and the United States, including a significant investment of $280 million in the US, Samsung Biologics is expanding its manufacturing footprint, offering opportunities for clients to collaborate on onshore production and regional supply chain solutions.

Strategic Partnerships Recent collaborations with Rapid Micro Biosystems and Lilly demonstrate Samsung Biologics’ openness to innovative technology and strategic alliances, signaling potential areas for joint ventures or technology integration projects.

Awards and Recognition Recognition as 'Best in Class' in cultural fit and top industry awards position Samsung Biologics as a preferred partner built on collaboration and operational excellence, making it a compelling prospect for long-term, strategic partnerships.